UNCY

3.3505.10%
JW

John W. Townsend

Chief Financial Officer

Mr. John W. Townsend, C.P.A., serves as the Chief Financial Officer of Unicycive Therapeutics, Inc. since March 2021, and he has previously served as Vice President Finance and Chief Accounting Officer in a consulting role since September 2020. Mr. Townsend had been Controller at Guardion Health Sciences, Inc. since July 1, 2016 until September 02, 2020 and had been its Chief Accounting Officer since March 2017 until September 02, 2020. Mr. Townsend served as a Controller of Cytori Therapeutics, Inc since Jan 2005 until August 15, 2015 and also served as its Chief Accounting Officer until August 15, 2015. Mr. Townsend worked at Cosmederm Biosciences, Inc., a specialty pharmaceutical company. From 1996 to 2005, he worked at several high-tech companies, and he started his career at Deloitte (formerly Deloitte and Touche) after graduating from San Diego State University in 1993. Mr. Townsend is a Certified Public Accountant in the state of California.

Positions